Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Effic Published Date December 15, 2022 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen